Paul Hudson has been CEO of Sanofi since September 2019. Previously, he was CEO of Novartis Pharmaceuticals from 2016 to 2019. Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and served as president, AstraZeneca US and executive vice president, North America. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synth?labo UK.
Soaring U.S. debt is causing Treasury bonds to lose their risk advantage over other securities, making it more expensive to...
Tehran: Iran will resume international flights on Monday from Mashhad airport in the country's northeast, its civil aviation authority said."Permission...
The S&P 500 has had a volatile year so far. However, the benchmark is up 4% in 2026 (as of...
Blue Origin’s flagship New Glenn rocket launched to space on its third flight, reusing a booster for the first time...
Canada’s Department of National Defense has decided to test the operation of Elbit Systems Ltd. (Nasdaq: ESLT; TASE:ESLT) Hermes...
A version of this post first appeared at TKer.co As much as I enjoy the intellectual exercise of researching and...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
